GlassScriptPhysician profile
Whitney Buchanan
NPI 1336795483
$1,988.58
in general payments reported to CMS, 2019-2025
11 companies · $1,900 in 2025
The $1,900 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $88.19 · 2025: $1,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,075 · Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,075.31 |
| Food and Beverage | $913.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,311.52 | 2025 | Ams 700, Rezum Generator |
| Janssen Biotech, INC. | $142.47 | 2024-2025 | Erleada |
| Vertex Pharmaceuticals Incorporated | $108.76 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $95.90 | 2025 | Adstiladrin |
| Teleflex LLC | $79.96 | 2025 | Barrigel, Urolift |
| Urogen Pharma, INC. | $74.50 | 2025 | |
| Sumitomo Pharma America, INC. | $68.11 | 2024-2025 | Orgovyx |
| Endo USA, INC. | $46.72 | 2025 | Xiaflex |
| Pfizer INC. | $27.79 | 2025 | |
| Axonics, INC. | $17.45 | 2024 | Axonics |
| Antares Pharma, INC. | $15.40 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.